Konrad Jersak

PALB2 mutations and prostate cancer risk and survival

Dominika Wokołorczyk, Wojciech Kluźniak, Klaudia Stempa, Bogna Rusak et autres

pl, ca (code pays fourni par la source)

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

Andrzej Antczak, Wojciech Kluźniak, Dominika Wokołorczyk, Aniruddh Kashyap et autres

pl (code pays fourni par la source)

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

Aniruddh Kashyap, Wojciech Kluźniak, Dominika Wokołorczyk, Adam Gołąb et autres

Several single nucleotide polymorphisms (SNPs) have been associated with an elevated risk of prostate cancer risk. It is not established if they are useful in predicting the presence of prostate cancer at biopsy or if they can be used to define a …

pl, ca (code pays fourni par la source)

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

Wojciech Kluźniak, Dominika Wokołorczyk, Aniruddh Kashyap, Anna Jakubowska et autres

BACKGROUND: The G84E mutation in the HOXB13 gene has been associated with a high lifetime risk of prostate cancer in North America (about 20-fold). The geographical and ethnic extent of this recurrent allele has not yet been determined. METHODS: We assayed for …

pl, ca (code pays fourni par la source)

An inherited NBN mutation is associated with poor prognosis prostate cancer

Cezary Cybulski, Dominika Wokołorczyk, Wojciech Kluźniak, Anna Jakubowska et autres

BACKGROUND: To establish the contribution of eight founder alleles in three DNA damage repair genes (BRCA1, CHEK2 and NBS1) to prostate cancer in Poland, and to measure the impact of these variants on survival among patients. METHODS: Three thousand seven hundred fifty …

pl, ca (code pays fourni par la source)